International Journal of Clinical Pharmacy
First published: 27 December 2017
Noh, Y., Lee, J., Shin, S. et al. Int J Clin Pharm
Objective: To determine the effect of cilostazol in combination with ACEI or ARB treatment on the decline in eGFR. Setting A tertiary hospital in Korea.
Methods: In an observational cohort study, we analyzed 5505 patients who were prescribed ACEI or ARB and cilostazol or other antiplatelet agents.